Ducommun Incorporated has had a remarkable week — up 14% to $185.21 — and the Street is scrambling to catch up.
The catalyst is clear. On Tuesday, Citigroup's John Godyn raised his price target from $167 to $216, maintaining a Buy rating, hours after the stock had already sprinted past his prior target. That single move is notable: a bellwether firm lifting its target by nearly 30% in one revision signals conviction, not housekeeping. The broader analyst picture reinforces the direction. Multiple firms have raised targets since DCO's strong Q1 print in mid-May — B. Riley moved to $187, Goldman Sachs to $151, RBC to $155, Truist to $150 — all while keeping positive ratings intact. The Street consensus mean stands at $173.80, now comfortably below where the stock trades. Citigroup's $216 target is the outlier pulling the herd upward.
The positioning backdrop tells a more complicated story. Short interest has climbed meaningfully — up 17% over the week to nearly 5.9% of free float — even as the stock surged. That's an unusual divergence: bears adding exposure into a 14% weekly gain. Borrowing remains extremely cheap at under 0.5%, and availability is actually loose at roughly 789% of outstanding short interest, meaning the lending pool is far from strained. With 8 million shares available to borrow versus fewer than 900,000 shorted, there's no squeeze dynamic building here. The ORTEX short score has nudged higher, from around 42 two weeks ago to 45.3 now, reflecting the rising short interest count — but it ranks in only the 23rd percentile of the universe, suggesting shorts remain a modest rather than aggressive force. Options confirm the bullish lean: the put/call ratio is running at 0.11, near the low end of its 52-week range and slightly below its 20-day average, meaning call activity heavily dominates.
Valuation has re-rated sharply with the price. The price-to-earnings multiple now runs at 36x, having expanded roughly 4 points over the past month, and EV/EBITDA is at 17.2x. The price-to-book ratio has moved up 0.4 points over 30 days to 3.4x. These are not cheap multiples for an aerospace components supplier, and the gap between current price and the Street's average target is the real tension: DCO at $185 is trading 6.5% above the consensus mean, relying on Citigroup's freshly raised $216 as the credible ceiling. The factor profile adds nuance — EPS momentum over 30 days ranks in the 64th percentile, a decent reading, but the 90-day momentum score drops to 33, and value ranks just in the low-30s percentile. Momentum is doing the heavy lifting.
Among correlated peers, DCO's 14% week stands apart. LOAR put in a comparable 12.6%, and AIR gained 8%. But CW, ATRO, and WWD were all flat to slightly negative on the week, suggesting the DCO move reflects stock-specific catalyst rather than a uniform sector tailwind. BA barely moved, adding 0.1% — further evidence that DCO's week had its own driver.
The insider picture complicates the thesis modestly. In mid-May, shortly after the Q1 earnings beat that sent the stock up 7% in a single session, the CEO, CFO, SVP, General Counsel, and HR Director all sold stock — a cluster of coordinated post-earnings disposals. These were small in aggregate relative to the float, but the pattern of insider selling into strength is worth tracking as the next earnings date approaches on August 13.
With Citigroup's $216 target now acting as the ceiling the market is pricing toward, and short sellers stubbornly rebuilding positions into the rally, the August 13 earnings print becomes a binary moment — the question being whether DCO can deliver the kind of operational beat that closes the gap between current price and an already-elevated analyst target.
See the live data behind this article on ORTEX.
Open DCO on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
